Cargando…

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells

Cervical cancer ranks fourth among the most commonly diagnosed malignant tumors in women worldwide. Previously published evidence suggested a possible connection between the expression of the membrane-bound heparan sulfate proteoglycan syndecan-1 (Sdc-1) and the development of cervical carcinoma. Sd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilgers, Katharina, Ibrahim, Sherif Abdelaziz, Kiesel, Ludwig, Greve, Burkhard, Espinoza-Sánchez, Nancy A., Götte, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828476/ https://www.ncbi.nlm.nih.gov/pubmed/35155241 http://dx.doi.org/10.3389/fonc.2022.803899

Ejemplares similares

The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis
por: Hillemeyer, Lara, et al.
Publicado: (2022)

Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes
por: Nassar, Eyyad, et al.
Publicado: (2021)

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
por: Ibrahim, Sherif A., et al.
Publicado: (2013)

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2017)

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
por: Götte, Martin, et al.
Publicado: (2007)

Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells
por: Katakam, Sampath Kumar, et al.
Publicado: (2020)

Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
por: Wischmann, Franz-Josef, et al.
Publicado: (2023)

The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor
por: Hassan, Nourhan, et al.
Publicado: (2023)

Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells
por: Valla, Sofía, et al.
Publicado: (2021)

Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
por: Oto, Julia, et al.
Publicado: (2023)

Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer
por: Ahmed, Sarah Hamdy, et al.
Publicado: (2021)

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
por: Motta, Juliana Maria, et al.
Publicado: (2023)

Syndecan-1 as a Regulator of Chemokine Function
por: Götte, Martin, et al.
Publicado: (2003)

Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis
por: Stejskalová, Anna, et al.
Publicado: (2021)

The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients
por: Saleh, Moshira Ezzat, et al.
Publicado: (2019)

Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer
por: Troschel, Fabian M., et al.
Publicado: (2020)

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
por: Péterfia, Bálint, et al.
Publicado: (2012)

Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis
por: Strauß, Theresa, et al.
Publicado: (2022)

Low Soluble Syndecan-1 Precedes Preeclampsia
por: Gandley, Robin E., et al.
Publicado: (2016)

Soluble syndecan-1 and glycosaminoglycans in preeclamptic and normotensive pregnancies
por: Hassani Lahsinoui, H., et al.
Publicado: (2021)

Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer
por: Onyeisi, Jessica Oyie Sousa, et al.
Publicado: (2021)

Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value
por: Fahim, Sarah Atef, et al.
Publicado: (2020)

Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies
por: Mundt, Filip, et al.
Publicado: (2014)

Aberrant Expression of Syndecan-1 in Cervical Cancers
por: Karászi, Katalin, et al.
Publicado: (2020)

HS2ST1‐dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior
por: Vijaya Kumar, Archana, et al.
Publicado: (2020)

S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation
por: Lam, David CL, et al.
Publicado: (2015)

A cytoplasmic C-terminal fragment of syndecan-1 is generated by sequential proteolysis and antagonizes syndecan-1 dependent lung tumor cell migration
por: Pasqualon, Tobias, et al.
Publicado: (2015)

Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis
por: Eustace, Andrew D., et al.
Publicado: (2019)

N-syndecan deficiency impairs neural migration in brain
por: Hienola, Anni, et al.
Publicado: (2006)

Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas
por: El-Nadi, Mennatullah, et al.
Publicado: (2020)

Prognostic significance of syndecan-1 expression in cervical cancers
por: Kim, Yu Im, et al.
Publicado: (2011)

Role of syndecan-1 in the interaction between dendritic cells and T cells
por: Kouwenberg, M., et al.
Publicado: (2020)

Editorial: Cancer stem cells as attractive targets for breast cancer therapy
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2023)

miR-142-3p Reduces the Size, Migration, and Contractility of Endometrial and Endometriotic Stromal Cells by Targeting Integrin- and Rho GTPase-Related Pathways That Regulate Cytoskeletal Function
por: Börschel, Christin S., et al.
Publicado: (2020)

Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling
por: Bernemann, Christof, et al.
Publicado: (2014)

Novel Processed Form of Syndecan-1 Shed from SCC-9 Cells Plays a Role in Cell Migration
por: Aragão, Annelize Z. B., et al.
Publicado: (2012)

Physiological and anatomical aspects of the reproduction of mice with reduced Syndecan-1 expression
por: Gougoula, Christina, et al.
Publicado: (2019)

Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21(WAF1/CIP1)
por: Troschel, Fabian M., et al.
Publicado: (2021)

Analysis of Toll-Like Receptors in Human Milk: Detection of Membrane-Bound and Soluble Forms
por: Cattaneo, Chiara, et al.
Publicado: (2019)

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients
por: Olah, Csilla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l3u4uqbut8p0cthogrfi2a4042